<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.vetbiolix.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.vetbiolix.com/press/</loc>
		<lastmod>2026-03-26T13:12:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-completes-a-series-a-fundraising-of-e4m-and-launches-the-european-regulatory-clinical-development-of-its-first-in-class-drug-candidates-targeting-osteoarthritis-and-canine/</loc>
		<lastmod>2026-02-13T16:39:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-communicates-on-the-final-results-of-the-proof-of-concept-study-of-vbx-2000-piclidenoson-in-canine-osteoarthritis-and-on-the-upcoming-submission-of-a-regulatory-pilot-study-vs-placebo/</loc>
		<lastmod>2026-02-13T17:05:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-communicates-interim-positive-results-from-the-proof-of-concept-clinical-study-of-its-drug-candidate-vbx-2000-piclidenoson-a3r-agonist-in-dogs-suffering-from-osteoarthritis/</loc>
		<lastmod>2026-02-13T17:15:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-announces-positive-results-of-the-proof-of-concept-clinical-study-of-its-drug-candidate-vbx-1000-in-periodontal-disease-in-dogs/</loc>
		<lastmod>2026-02-13T17:31:31+00:00</lastmod>
		<image:image>
			<image:loc>https://www.vetbiolix.com/wp-content/uploads/2026/02/Poster-SWAVA-2024_V1.0_2024.08.31-scaled.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-strengthens-its-top-management-with-the-arrival-of-dr-karine-bertrand-as-chief-pharmaceutical-technical-officer-board-member/</loc>
		<lastmod>2026-02-13T17:33:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-and-raqualia-pharma-enter-into-an-agreement-to-develop-pet-pharmaceuticals-for-the-treatment-of-gut-motility-disorders-in-pets/</loc>
		<lastmod>2026-02-13T17:38:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-raises-e2-5-million-in-funds-and-launches-the-clinical-development-of-its-first-in-class-drug-candidates-in-dogs-and-cats-for-periodontal-diseases-and-osteoarthritis/</loc>
		<lastmod>2026-02-13T17:40:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/can-fites-partner-vetbiolix-is-heading-into-a-european-multicentric-clinical-trial-with-piclidenoson-for-the-treatment-of-pets-osteoarthritis/</loc>
		<lastmod>2026-02-13T17:42:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/can-fite-enters-projected-3-billion-veterinary-osteoarthritis-market-signs-agreement-with-vetbiolix-for-development-of-piclidenoson-for-pets/</loc>
		<lastmod>2026-02-27T14:07:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/test/</loc>
		<lastmod>2026-02-27T14:18:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-announces-publication-of-landmark-proof-of-concept-clinical-study-results-for-vbx-1000-in-canine-periodontitis-in-frontiers-in-veterinary-science/</loc>
		<lastmod>2026-03-26T13:08:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.vetbiolix.com/press/vetbiolix-announces-initiation-of-randomized-placebo-controlled-study-to-confirm-clinical-benefit-with-vbx-1000-miv-701-in-canine-periodontitis/</loc>
		<lastmod>2026-03-26T13:12:10+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->